Aika Lab is at the intersection of neuroscience, AI, and consumer wellness. We are building the world's first closed-loop neuroacoustic sleep enhancement platform.
Market
$80B+
Global sleep health market by 2030
Technology
CLAS
First closed-loop acoustic BCI for sleep
Hardware
250 Hz
EEG sampling rate, BLE 5.0 latency
Stage
Seed
Building towards Series A
CLAS is backed by peer-reviewed neuroscience (Ngo et al., 2013). Our ecHT real-time phase estimator is purpose-built for low-latency BLE environments — not adapted from clinical hardware.
We run on $150 dry-electrode BCI headsets, not $10,000 hospital PSG systems. This is what democratizes access to deep sleep enhancement.
Android-first with iOS and WeChat Mini App in roadmap. Targeting Sweden, EU, and China simultaneously.
Every session generates labeled EEG + stimulation outcome data. Our dataset grows with each user night, creating compounding model improvement.
B2B licensing of the AIKA SDK to other app developers, hardware manufacturers, and clinical research organizations generates recurring revenue.
We are selectively meeting with investors aligned with BCI, digital health, and longevity.
Please include a brief intro and your fund focus in your message.
Request Deck →